Skip to main content
Equibles

MetLife Investment Management, LLC

Position in ARDX — Ardelyx, Inc.

CIK 1529735 Whippany, NJ
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$727,525
-$69,174 QoQ
Shares Held
142,652
+7.3% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 250 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. ARDX ranks #103 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in ARDX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $727,525 142,652
2026-03-31 $796,699 133,005
2025-12-31 $694,370 119,103
2025-09-30 $756,534 137,302
2025-03-31 $646,264 131,622
2024-12-31 $685,240 135,156
2024-09-30 $860,857 124,943
2024-06-30 $1,011,620 136,521
2024-03-31 $850,026 116,442
2023-12-31 $753,622 121,552
2023-09-30 $458,942 112,486
2023-06-30 $381,327 112,486
2021-06-30 $247,077 32,596
2021-03-31 $91,786 13,865
2020-12-31 $212,209 32,799
2020-09-30 $180,815 34,441
2020-06-30 $256,088 37,007
2020-03-31 $144,012 25,332